20-Week Breakout Analysis — 2026-10-31

Overview

The 20-Week Breakout scan registered 237 total signals on 2026-10-31: 111 bullish (46.8%) versus 126 bearish (53.2%). This near-even split places the tape in a balanced-to-cautious posture rather than outright distribution — institutions are rotating capital selectively rather than fleeing broadly. That aligns with the SA Regime reading of Cautious, where breadth is soft (49.7% of names above SMA-40) and sentiment skews Very Bearish/Neutral.

Leadership has rotated defensively: Utilities (3.5% ATR%), Materials (3.0%), and Consumer Staples (2.6%) are the hottest sectors, while Financials, Communication Services, and Technology are lagging with negative ATR%. That is a classic late-cycle, risk-off rotation signature even as individual large-cap breakouts (TSLA, REGN, VRTX) persist.

Quality Score: 3/5. Signal count is healthy and bullish breadth spans Medical, Software, Aerospace/Defense, and Real Estate, but the Cautious regime caps conviction — institutional fund-count data is largely unreported (0 funds flagged across all top movers), and bearish signals slightly outnumber bullish ones. Only the highest-ATR-multiple, high-relative-volume setups (REGN, ICLR, VRTX) merit elevated conviction; the rest warrant tactical, not aggressive, sizing.

Top 5 Bullish Picks

CACI ($675.06) — Business Services / Computer-Tech Services

Open full analysis on WaveFinder →

CACI posted a 20-week dollar breakout with a 2.67 ATR multiple on a tight 3.0% ADR%, sitting just 1.2% off its 52-week high and 55.3% above its 52-week low. Relative volume of 0.6 suggests the move was driven by steady institutional accumulation rather than a volume spike — a slow-grind breakout typical of defense-adjacent tech services names holding up in a Cautious tape.

Level	Price
Entry	$675.06
Stop (2x ATR)	$634.28
Target 1 (2x ATR)	$715.84
Target 2 (4x ATR)	$756.62

Institutional Interest: 0 funds reported, fund % increase undefined, bucket funds_500. Data limited; monitor for fund disclosures next cycle.

TSLA ($399.81) — Auto / Auto Manufacturers

Open full analysis on WaveFinder →

Tesla’s breakout came with a 2.43 ATR multiple and relative volume of 1.1x on heavy absolute turnover (41.3M shares), confirming genuine demand. The stock remains 19.9% below its 52-week high but 34.4% above its low, and the elevated LOD Risk ATR% (91.4%) signals wide intraday swings — a high-reward, high-volatility setup.

Level	Price
Entry	$399.81
Stop (2x ATR)	$372.93
Target 1 (2x ATR)	$426.69
Target 2 (4x ATR)	$453.57

Institutional Interest: 0 funds reported, bucket funds_1000. Large bucket classification implies broad institutional eligibility despite unreported fund count.

ICLR ($211.36) — Medical / Medical-Research

Open full analysis on WaveFinder →

ICLR is the standout mover: a 5.09 ATR multiple paired with 2.9x relative volume (2.58M vs 904K average) signals an institutional-grade breakout. The stock is just 3.5% off its 52-week high and an extraordinary 217.5% above its 52-week low, reflecting a durable multi-quarter uptrend accelerating into this breakout week.

Level	Price
Entry	$211.36
Stop (2x ATR)	$192.32
Target 1 (2x ATR)	$230.40
Target 2 (4x ATR)	$249.44

Institutional Interest: 0 funds reported, bucket funds_500. High volume surge despite unreported fund count suggests emerging institutional interest not yet captured in data feed.

CSL ($376.20) — Diversified Operations

Open full analysis on WaveFinder →

CSL’s breakout carries a strong 3.96 ATR multiple on near-average relative volume (0.9x), indicating a controlled, trend-following advance rather than a news-driven spike. The stock is 13.1% off its high but 28.2% above its 52-week low, fitting the broader rotation into diversified/defensive operators favored in this Cautious regime.

Level	Price
Entry	$376.20
Stop (2x ATR)	$353.98
Target 1 (2x ATR)	$398.42
Target 2 (4x ATR)	$420.64

Institutional Interest: 0 funds reported, bucket funds_1000. Large-cap bucket size supports eventual institutional disclosure.

REGN ($927.89) — Medical / Profitable Biotech

Open full analysis on WaveFinder →

REGN delivered the highest-conviction setup in the scan: a 5.81 ATR multiple with 4.0x relative volume (2.85M vs 718K average), pushing the stock to 8.0% above its 52-week high — a fresh breakout to new highs. The 56.9% gain above its 52-week low confirms sustained biotech sector strength even amid broader market caution.

Level	Price
Entry	$927.89
Stop (2x ATR)	$873.69
Target 1 (2x ATR)	$982.09
Target 2 (4x ATR)	$1036.29

Institutional Interest: 0 funds reported, bucket funds_1000. New-high breakout on 4x volume is the strongest signal in today’s bullish set.

Bearish Alerts

RDDT (-$65.2% off 52W high, -3.61 ATR multiple, 5.4x relative volume) shows the most severe breakdown, with volume confirming heavy distribution in Internet-Content. LSTR (-3.84 ATR multiple, 1.6x rel volume) and MDGL (-3.61 ATR multiple) also show sharp downside acceleration in Transportation-Truck and Revenue Biotech respectively. ADBE’s breakdown (-31.0% off high) in Software echoes the Technology sector’s negative ATR% reading, reinforcing that large-cap tech weakness is broad-based, not idiosyncratic.

Sector Theme

Today’s cross-sector signal confirms a defensive rotation: Utilities, Materials, and Consumer Staples lead on ATR%, while Financials, Communication Services, and Technology lag. Bullish breakouts cluster in Medical/Biotech, Business Services, and Diversified Operations — sectors less sensitive to rate and growth scares. Bearish breakdowns concentrate in Software, Internet-Content, and Transportation, consistent with the Technology sector’s -1.9% ATR% reading and broader risk-off positioning.

Institutional Summary

Fund-count data was unreported (0 funds) across every top bullish and bearish ticker today, limiting direct accumulation tracking. However, volume-based proxies point to institutional engagement in REGN (4.0x relative volume, new 52-week high) and ICLR (2.9x relative volume, 5.09 ATR multiple) as the strongest accumulation candidates. Bucket classifications (funds_1000 for TSLA, CSL, REGN, VRTX, JLL, TDY) suggest these remain broadly held large-cap names eligible for institutional disclosure in future cycles.

Signals